InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Soon-Shiong Patrick. Officer active across 2 companies, notably ImmunityBio, Inc.. In total, 8 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €5.5m. History available since 12 December 2022. The latest transaction was disclosed on 31 March 2026 (C). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
SOON-SHIONG PATRICK is a declarant linked to ImmunityBio, Inc. and NantHealth, Inc., where his listed role is Chief Executive Officer. The record shows 8 filings in total, and across the sampled recent filings, buys amount to EUR 5542440 and sells to EUR 0, over the period from 2022-12-14 to 2026-04-02.